Table 1.
Metabolites | Methods | NSNP | Beta | SE | P | OR |
---|---|---|---|---|---|---|
Citrate | IVW | 3 | 0.213 | 0.106 | 0.0452 | 1.24 (1.01–1.52) |
MR-Egger | 3 | 0.914 | 1.67 | 0.681 | 2.49 (0.09–65.84) | |
M.VLDL.C | IVW | 11 | 0.121 | 0.0573 | 0.0349 | 1.13 (1.01–1.26) |
MR-Egger | 11 | −0.0653 | 0.134 | 0.6374 | 0.94 (0.72–1.22) | |
S.VLDL.P | IVW | 12 | 0.0944 | 0.0462 | 0.0411 | 1.10 (1.00–1.20) |
MR-Egger | 12 | −0.0664 | 0.119 | 0.590 | 0.94 (0.74–1.18) |
VLDL: Very low density lipoprotein; M.VLDL.C: Total cholesterol in medium VLDL; S.VLDL.P: Concentration of small VLDL particles. SE: standard error. The statistically significant association of IVW is defined to be P < 0.05/123 = 0.00041. The statistically significance of no horizontal pleiotropy is defined to be P > 0.05.